Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Zimmer Biomet Holdings, Inc. (ZBH) announced FDA De Novo classification grant and authorization to market the tibial extension for Persona IQ Knee Implant which allows surgeons to monitor patients' post-operative progress.


RTTNews | Aug 30, 2021 07:45AM EDT

07:45 Monday, August 30, 2021 (RTTNews.com) - Zimmer Biomet Holdings, Inc. (ZBH) announced FDA De Novo classification grant and authorization to market the tibial extension for Persona IQ Knee Implant which allows surgeons to monitor patients' post-operative progress.

Persona IQ features the CANARY canturio te Tibial Extension implantable sensor developed by Canary Medical, a medical data company. Using the same material and technology found in implanted cardiac devices such as pacemakers, the CANARY canturio te measures and determines range of motion, step count, walking speed and other gait metrics. Persona IQ wirelessly transmits the recorded gait data to a patient's personal base station.

Persona IQ will work together with Zimmer Biomet's remote care management platform, mymobility with Apple Watch, and other components of the ZBEdge Connected Intelligence Suite.

Read the original article on RTTNews ( https://www.rttnews.com/3221794/zimmer-biomet-to-debut-smart-knee-implant-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC